Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Podocyte stabilization pathway" is not a single molecule or receptor but refers collectively to the network of cellular processes and molecular interactions that maintain the structural and functional integrity of podocytes—specialized epithelial cells critical for kidney filtration. These pathways involve regulation of the actin cytoskeleton, maintenance and repair of slit diaphragms between foot processes, crosstalk with endothelial cells via factors like VEGF, calcium signaling through channels such as TRPC6, and turnover/endocytosis mechanisms for membrane proteins. Disruption in these stabilizing processes leads directly to proteinuric kidney diseases including minimal change disease, FSGS, diabetic nephropathy, and others[1][2][3][4][5]. Therapeutic interventions often target key molecules within these pathways rather than the entire process.
Inhibition of synaptopodin degradation to stabilize actin cytoskeleton
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Podocyte stabilization pathway.